Ibrahim, Andrea Marie
Le May, Melanie
Bossé, Dominick
Marginean, Horia
Song, Xinni
Nessim, Carolyn
Ong, Michael
Article History
Received: 28 October 2019
First Online: 3 May 2020
Change Date: 22 May 2020
Change Type: Correction
Change Details: In the original article, the survival curves are missing in Fig.��1c, d.
Disclosures
: All authors read and approved the manuscript. This manuscript has not previously been published and is not currently under consideration for publication in any other journal. Michael Ong has been a consultant to and received honoraria from Bristol-Myers Squibb, Merck, AstraZeneca, and Roche/Genentech. Carolyn Nessim has received honoraria from Merck, EMD Serono and Novartis, and has been on an advisory board for Novartis. Xinni Song has been a consultant to and received honoraria from Bristol-Myers Squibb and Merck. Dominick Bossé has been a consultant to Bristol-Myers Squibb, Pfizer and AbbVie, and has received honoraria from AstraZeneca, Ipsen, Amgen and Janssen. Andrea Marie Ibrahim, Melanie Le May, and Horia Marginean declare they have no competing interests.